Instil Bio Inc (TIL)
65.62
-2.74
(-4.01%)
USD |
NASDAQ |
Sep 27, 16:00
65.80
+0.18
(+0.27%)
After-Hours: 20:00
Instil Bio Research and Development Expense (Annual): 39.60M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 39.60M |
| December 31, 2022 | 141.06M |
| December 31, 2021 | 107.25M |
| Date | Value |
|---|---|
| December 31, 2020 | 19.40M |
| December 31, 2019 | 4.027M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
4.027M
Minimum
2019
141.06M
Maximum
2022
62.27M
Average
39.60M
Median
2023
Research and Development Expense (Annual) Benchmarks
| Merck & Co Inc | 30.53B |
| BioCardia Inc | 7.726M |
| Zevra Therapeutics Inc | 39.81M |
| PetIQ Inc | -- |
| SeaStar Medical Holding Corp | 5.973M |